+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Evaluation of intrapericardial cisplatin administration in cases of recurrent malignant pericardial effusion and cardiac tamponade



Evaluation of intrapericardial cisplatin administration in cases of recurrent malignant pericardial effusion and cardiac tamponade



Pneumonologia i Alergologia Polska 64 Suppl 2: 180-186



30 consecutive patients with large malignant pericardial effusion (MPE) entered this prospective study. After pericardiocentesis and insertion of a polyurethane catheter, pericardial fluid was drained. Malignant etiology of pericardial fluid was confirmed by cytological examination. After confirmation of MPE cisplatin (10 mg in 20 ml normal saline) was instilled over 5 minutes during 5 consecutive days directly into pericardial space. If fluid reaccumulation occurred the courses were repeated every 3 weeks. Treatment was considered successful if the patient with malignant effusion survived 30 days without recurrence of symptoms of large pericardial effusion and other interventions directed to the pericardium were required. Positive effect of intrapericardial treatment with cisplatin was achieved in 18 cases (60%). Mean period of response was 3, 7 months (+/-6). Cisplatin administered directly into pericardial space is effective and safe method of treatment of recurrent MPE. Sclerosis of the pericardial space is rare complication connected with CP. Positive effect of CP can depend on improvement of lymphatic drainage from heart. CP seems to be method of choice in intal intrapericardial treatment in patients with malignant cardiac tamponade and recurrent MPE in course of lung cancer.

(PDF emailed within 1 workday: $29.90)

Accession: 046010747

Download citation: RISBibTeXText

PMID: 9181888


Related references

Evaluation of intrapericardial cisplatin administration in cases with recurrent malignant pericardial effusion and cardiac tamponade. Supportive Care in Cancer 12(1): 53-57, 2003

Intrapericardial instillation of mitomycin C in recurrent cardiac tamponade due to malignant pericardial effusion. Clinical Oncology ) 18(6): 506, 2006

Intrapericardial tetracycline for the management of cardiac tamponade secondary to malignant pericardial effusion. New England Journal of Medicine 299(20): 1113-1114, 1978

Intrapericardial bleomycin for the management of cardiac tamponade secondary to malignant pericardial effusion. British Heart Journal 63(1): 61-62, 1990

Prolonged Drainage and Intrapericardial Bleomycin Administration for Cardiac Tamponade Secondary to Cancer-Related Pericardial Effusion. Medicine 95(15): E3273, 2016

Intrapericardial cisplatin administration after pericardiocentesis in patients with lung adenocarcinoma and malignant cardiac tamponade. Hellenic Journal of Cardiology 46(5): 324-329, 2005

Intrapericardial cisplatin in malignant pericardial effusion. European Journal of Cancer 27(SUPPL 3): S57, 1991

Pericardial effusion and cardiac tamponade caused by intrapericardial granulation tissue in a dog. Journal of Veterinary Emergency and Critical Care 19(2): 187-192, 2009

Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion. Journal Of Cancer Research & Clinical Oncology. 120(7): 434-436, 1994

A case of pericardial tamponade caused by recurrent breast cancer treated with intrapericardial and intrapleural infusion of cisplatin (CDDP). Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(8): 1133-1136, 2006

Pericardiocentesis with cisplatin for malignant pericardial effusion and tamponade. World Journal of Gastroenterology 16(6): 740-744, 2010

Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion in the course of the lung cancer. Lung Cancer 16(2-3): 215-222, 1997

Laparoscopic transabdominal pericardial window: new standard in the treatment of recurrent pericardial effusion complicated by cardiac tamponade. Surgical Endoscopy 16(5): 859-863, 2002

Pericardial sclerosis as the primary management of malignant pericardial effusion and cardiac tamponade. Journal of Thoracic and Cardiovascular Surgery 112(3): 637-643, 1996

Intrapericardial Cisplatin Instillation in Recurrent Postinfarction Cardiac Tamponade. Journal of Cardiothoracic and Vascular Anesthesia 32(1): 458-460, 2017